PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1-Reference-Cited by-同舟云学术

PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1

Published:1998-12 Issue:12 Volume:66 Page:1604-1611
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

McDiarmid Sue V.,Jordan Stan,Lee Geoffrey S.,Toyoda Meiko,Goss John A.,Vargas Jorge H.,Mart??n Mart??n G.,Bahar Ron,Maxfield Anne L.,Ament Marvin E.,Busuttil Ronald W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference56 articles.

1. POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATION

2. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern

3. A RECENT DECREASE IN THE TIME TO DEVELOPMENT OF MONOMORPHOUS AND POLYMORPHOUS POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER

Cited by 302 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant Lymphoproliferative Disorder Presenting as a Gastrointestinal Fistulous Tract in a Heart Transplant Recipient: Case Report and Literature Review;Transplantation Proceedings;2024-08

2. Post‐transplant lymphoproliferative disorder associated Epstein‐Barr virus DNAemia after liver transplantation in children: Experience from single center;Journal of Medical Virology;2024-06

3. Kidney transplantation: Assessment of the Kidney Donor Candidate;Living Donor Organ Transplantation;2024

4. Epstein–Barr Viral Load Monitoring Strategy and the Risk for Posttransplant Lymphoproliferative Disease in Adult Liver Transplantation;Annals of Internal Medicine;2023-02

5. Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation;Frontiers in Pediatrics;2023-01-10